| Biomarker ID | 1808 |
| PMID | 30352818 |
| Year | 2018 |
| Biomarker | Albumin |
| Biomarker Basis | Concentration Based |
| Biomolecule | Metabolites |
| Source | Blood |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: 1.104 (95% CI: 1.043-1.168) |
| Effect on Pathways | Pathway include: Response to elevated platelet cytosolic Ca2+; Lipoprotein metabolism; Folate Metabolism; Synthesis of bile acids and bile salts; Binding and Uptake of Ligands by Scavenger Receptors |
| Experiment | Prostate Cancer Vs No Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | For the study, 2291 PCa patients along with 2661 controls were selected for the study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.00065 |
| Method Used | Nuclear Magnetic Resonance (NMR) spectroscopy |
| Clinical | Yes |
| Remarks | NA |
| Clinical Trial Number | ISRCTN20141297 |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |